The Friedman Brain Institute

Stroke and Other Cerebrovascular Illnesses

The Mount Sinai Stroke Center is a leader in stroke research and treatment, in the areas of medical therapy for treating and preventing stroke, neurosurgical approaches to stroke prevention, and interventional neuroradiologic procedures for stroke patients.  

Advances in Stroke Research

Our research focuses on the prevention of stroke, the treatment of acute stroke, and on ways to help patients recover optimally from stroke. We are one of the 25 regional coordinating centers in a network recently established by the National Institute of Neurological Disorders and Stroke (NINDS) to develop and perform clinical trials in the prevention and acute management of all forms of stroke, as well as in stroke rehabilitation. We are currently involved in the following research:

  • A major barrier in stroke treatment is the underuse of stroke prevention therapies among minority populations.  We have conducted studies to determine the causes of this. We have also evaluated a program to address these causes in patients hospitalized at Mount Sinai and in surrounding communities. We are conducting these studies with the Department of Health Evidence and Policy and with funding from the Agency for Healthcare Research and Quality, the National Center on Minority Health and Health Disparities, and NINDS.
  • In conjunction with the Department of Neurosurgery, we are conducting studies, funded by the National Institutes of Health, assessing the efficacy of thrombolytic medication to help dissolve blood clots in patients with intracerebral bleeding.
  • In collaboration with the Division of Neuroradiology, we are examining the application of new computed tomography (CT) scans and magnetic resonance imaging (MRI) techniques on patients with stroke to provide quicker and more accurate diagnostic and prognostic information.
  • We are involved in a multicenter cooperative study to determine the safety and efficacy of a high-dose statin medication as a neuroprotective agent in acute ischemic stroke.

Scientists involved: Bernadette Boden-Albala, Mandip DhamoonRoland Friedel, Carol R. HorowitzAaron P. TansyStanley TuhrimJesse WeinbergerHongyan Zou

Advances in Patient Care

The Mount Sinai Health System offers advanced treatment for stroke based upon proven therapies for acute stroke and intracerebral hemorrhage. Learn more about how we are improving the prevention of stroke and recovery.

Make a Gift